NeRRe Therapeutics completes venture financing

NeRRe raised £23 million ($28.4 million) in a series B round co-led by new investors Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed. Advent Life Sciences, Novo A/S and existing inv...